4.7 Article

Personalized brachytherapy dose reconstruction using deep learning

期刊

COMPUTERS IN BIOLOGY AND MEDICINE
卷 136, 期 -, 页码 -

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.compbiomed.2021.104755

关键词

Brachytherapy; Dose reconstruction; Heterogeneity correction; Monte Carlo; Deep learning

资金

  1. Swiss National Science Foundation [SNRF 320030_176052]
  2. Private Foundation of Geneva University Hospitals [RC-06-01]
  3. Iran's Ministry of Science

向作者/读者索取更多资源

The study introduced a personalized brachytherapy dosimetry approach based on deep learning, which improves accuracy while avoiding the computational burden of Monte Carlo calculations and simplifications of TG-43. Experimental results showed that this method exhibited comparable performance to the Monte Carlo method in dose prediction.
Background and purpose: Accurate calculation of the absorbed dose delivered to the tumor and normal tissues improves treatment gain factor, which is the major advantage of brachytherapy over external radiation therapy. To address the simplifications of TG-43 assumptions that ignore the dosimetric impact of medium heterogene-ities, we proposed a deep learning (DL)-based approach, which improves the accuracy while requiring a reasonable computation time. Materials and methods: We developed a Monte Carlo (MC)-based personalized brachytherapy dosimetry simulator (PBrDoseSim), deployed to generate patient-specific dose distributions. A deep neural network (DNN) was trained to predict personalized dose distributions derived from MC simulations, serving as ground truth. The paired channel input used for the training is composed of dose distribution kernel in water medium along with the full-volumetric density maps obtained from CT images reflecting medium heterogeneity. Results: The predicted single-dwell dose kernels were in good agreement with MC-based kernels serving as reference, achieving a mean relative absolute error (MRAE) and mean absolute error (MAE) of 1.16 +/- 0.42% and 4.2 +/- 2.7 x 10(-4) (Gy.sec(-1)/voxel), respectively. The MRAE of the dose volume histograms (DVHs) between the DNN and MC calculations in the clinical target volume were 1.8 +/- 0.86%, 0.56 +/- 0.56%, and 1.48 +/- 0.72% for D90, V150, and V100, respectively. For bladder, sigmoid, and rectum, the MRAE of D5cc between the DNN and MC calculations were 2.7 +/- 1.7%, 1.9 +/- 1.3%, and 2.1 +/- 1.7%, respectively. Conclusion: The proposed DNN-based personalized brachytherapy dosimetry approach exhibited comparable performance to the MC method while overcoming the computational burden of MC calculations and over-simplifications of TG-43.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据